# Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial

> **NCT06985186** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of Palermo** · enrollment: 162 (estimated)

## Conditions studied

- Adenomyosis of Uterus
- Infertility Assisted Reproductive Technology

## Interventions

- **DRUG:** Ultra-Long GnRH Agonists + Letrozole
- **DRUG:** Ultra-Long GnRH Agonists

## Key facts

- **NCT ID:** NCT06985186
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06985186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06985186, "Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06985186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*